MOUNTAIN VIEW, Calif.,
Nov. 2, 2016 /PRNewswire/
-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of
medication management and supply chain solutions to health systems,
today introduced the Omnicell Performance Center, an integrated
services and software offering designed to drive improved pharmacy
operations through long-term partnerships with customers. This new
model of working with health system pharmacists, the first of its
kind for the industry, will advance more efficient operations,
helping customers to meet regulatory requirements, and ultimately
improve patient outcomes.
A recent study by the American Hospital Association and the
Federation of American Hospitals showed that between 2013 and 2015
inpatient drug spending increased an average 23.4 percent annually,
and on a per admission basis, by 38.7 percent.1 Omnicell
developed the Performance Center as a partner resource that
leverages foundational supply chain capabilities to reduce costs
and improve enterprise-wide management of one of the health
system's largest cost centers. Benefits of this unique
software and services offering include:
- Achieving enterprise-wide management of pharmacy
operations
- Improving inventory optimization, and ultimately reduction
- Leveraging strategic buying opportunities
- Mitigating drug shortages and reducing expired medications
- Automating manual process for central distribution
- Remaining compliant with 340B and CSOS regulations
Early customers of the Performance Center are saving an average
of 2% of their medication spend each year. The Performance
Center team of pharmacy and supply chain experts works with
hospital pharmacy leadership to establish long-term goals,
continuously mining customer data to provide meaningful but
manageable changes to achieve those goals. Regular tracking
progress is provided through a pharmacy scorecard.
"We recognize our customers face tremendous challenges trying to
optimize their pharmacy operations," said Randall Lipps, chairman, president, chief
executive officer and founder of Omnicell. "This is a paradigm
shift in how we view our customer relationships. It's no longer
sufficient to just provide leading technology. We have to partner
with our customers to ensure the highest level of cost containment
can be achieved. By providing real-time data and continuous
engagement, we are clearing obstacles and allowing our customers to
focus on delivering an exceptional patient experience." Visit
bit.ly/2e1EcUt to hear more about the Performance Center.
"Our organization needed a medication management strategy to
efficiently sustain growth in our system, while improving both
financial results and clinical care," said Steve Rough, director of pharmacy at the
University of Wisconsin Health and
Clinics, an early partner in pharmacy inventory
optimization. "Through a strategic, phased approach targeting
capital and maintenance, combined with reducing inventory, expired
medications and supply chain labor, we anticipate significant cost
savings over the next five-year period."
Performance Center offers a unique collaboration with the
partner health system to develop and implement incremental, yet
impactful changes designed to drive down cost while freeing up
critical resources.
"The pharmacy supply chain is not only one of the largest cost
centers for our system, it is also one of the most critical
elements of patient care," said Chris
Parrish, senior vice president Lab, Pharmacy, and Supply
Chain, Aultman Hospital. "This partnership is helping us to
identify significant savings opportunities through inventory
optimization, strategic buying, forecasting shortages, and reducing
medication waste, while giving our clinicians more time to focus on
patient care."
Omnicell will be showcasing the Performance Center at
the American Society of Health-System Pharmacists (ASHP)
51st Annual Midyear Clinical Meeting & Exhibition in
Las Vegas, December 5 through 7. To learn more, visit
www.omnicell.com/Products/Performance_Center.
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired
to create safer and more efficient ways to manage medications and
supplies across all care settings. As a leader in medication and
supply dispensing automation, central pharmacy automation, IV
robotics, analytics software, and medication adherence and
packaging systems, Omnicell is focused on improving care across the
entire health care continuum—from the acute care hospital setting,
to post-acute skilled nursing and long-term care facilities, to the
patient's home.
Over 4,000 customers worldwide use Omnicell automation and
analytics solutions to increase operational efficiency, reduce
medication errors, deliver actionable intelligence and improve
patient safety. The recent acquisition of Aesynt adds distinct
capabilities, particularly in central pharmacy and IV robotics,
creating the broadest medication management product portfolio in
the industry.
The Omnicell SureMed solution provides innovative medication
adherence packaging to help reduce costly hospital readmissions. In
addition, these solutions enable over 17,000 institutional and
retail pharmacies worldwide to maintain high accuracy and quality
standards in medication dispensing and administration while
optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please
visit www.omnicell.com.
OMCL-G
1 'Trends in Hospital Inpatient Drug Costs: Issues
and Challenges,' NORC. October
2016.
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products,
technology etc.) are issued exclusively by PR Newswire and are
immediately thereafter posted on the company's external
website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks
of Omnicell, Inc.
- All other brand or product names may be trademarks or
registered trademarks of their respective companies.
Logo -
http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/health-systems-to-realize-improved-financial-and-clinical-outcomes-through-omnicell-performance-center-300355849.html
SOURCE Omnicell, Inc.